Trial NRG-GY006


A Randomized Phase II Trial of Radiation Therapy and Cisplatin Alone or in Combination with Intravenous Triapine in Women with Newly Diagnosed Bulky Stage IB2, Stage II, IIIB, or IVA Cancer of the Uterine Cervix or Stage II-IVA Vaginal Cancer.

Type: Treatment
Phase: Phase III
Status: Not Open (Closed)
Treatments: Chemotherapy: Systemic, Radiation: External
Randomized: Yes
USC Satellite Location: None
Defintions of terms and FAQ about clinical trials.
Trial Leaders/Researchers:  Omar M Ragab, M.D.
Other Trial Staff:  Richa Aggarwal, D.M., Lusine Raddatz, D.M., Victoria Amran, D.M., Grace Facio, Coordinator, Marissa Aldana, D.M., Margarita Carranza, D.M., Shamim Jhimlee, Coordinator, America Casillas-Lopez, Coordinator, Laurie De Oliveira, Coordinator, Kristy Watkins, Coordinator

Staff may log in to see study documents.

Click here to see trial eligibility criteria and further details at ClinicalTrials.gov





For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or clinical.trials@med.usc.edu.

To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3300.